Home/Filings/4/0000899243-22-037224
4//SEC Filing

Tyagarajan Seshu 4

Accession 0000899243-22-037224

CIK 0001841387other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 6:26 PM ET

Size

9.8 KB

Accession

0000899243-22-037224

Insider Transaction Report

Form 4
Period: 2022-11-28
Tyagarajan Seshu
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2022-11-28+73,68473,684 total
Footnotes (1)
  • [F1]Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock upon vesting and settlement. 50% of the RSUs shall vest on November 28, 2023, and the remaining 50% on November 28, 2024, in each case subject to the Reporting Person's continued service on such vesting date.

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001923794

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 6:26 PM ET
Size
9.8 KB